~Emma~ asked: I’m looking into college and am going for the two year nursing program, and was wondering what kind of jobs are available for that kind of degree.
Thanks for your time!
-
Emma
Maybe a better way to phrase this is: What kind of jobs are open to RNs, As far as pharmaceuticals and hospitals go.
Please people, [...]
Anadys Pharmaceuticals, Inc. announced today that it will present at the 3rd annual BIOCOM Investor Conference on Monday, October 27, 2008 at 11:30 a.m. PDT at the Hyatt Regency La Jolla in San Diego, California.
Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will present an overview of Anadys and its three clinical programs: [...]
ohn S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. announces the appointment of Mel Sorensen, M.D. to the company’s Board of Directors.
Dr. Sorensen is currently Board Director, President and Chief Executive Officer of Ascenta Therapeutics. He is a highly experienced leader and administrator in cancer therapeutics and cancer drug [...]
Infinity Pharmaceuticals, Inc. (NasdaqGM:INFI – News), an innovative cancer drug discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its oral Hedgehog signaling pathway inhibitor, IPI-926, in patients with advanced and/or metastatic solid tumors.
IPI-926 is a novel, proprietary inhibitor of the Hedgehog signaling pathway. It is a derivative [...]
As millions of Americans participate in educational initiatives as part of National Breast Cancer Awareness Month, they should keep in mind an important yet under-recognized consequence of breast cancer therapy: oral mucositis, one of the most common and debilitating side effects of cancer treatment.
Oral mucositis (OM) is a painful inflammation/ulceration of the mucous membranes in [...]
Paratek Pharmaceuticals, Inc. today announced the Company’s lead product, amadacycline, formerly PTK 0796, a first-in-class aminomethylcycline, will be the subject of a Late Breaker poster presentation at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). ICAAC will be held in Washington, D.C. from October 25 – October 28, 2008.
More information on the poster [...]
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK – News), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that MiddleBrook President and CEO John Thievon will be presenting at the Rodman & Renshaw 10th Annual Healthcare Conference at the New York Palace Hotel in New York City on Nov. 11, 2008, at 12:00 [...]
A new share issue of 1,511 MSEK with preferential rights for the shareholders of Meda
• Each shareholder is offered to subscribe for one (1) new share for every six (6) shares held at the record date
• The subscription price is 35 SEK per share
• Term of subscription runs between November 10 and November 24, 2008
• [...]
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) (”Genomma” or “the Company”), a leading Mexican over-the-counter pharmaceuticals and personal care products company announced that it has no additional information related to today’s stock price movements and considers that the variation in the stock price was singularly due to normal fluctuations due to the market conditions [...]
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has been named by Science magazine as a top employer in the biotechnology and pharmaceutical industries, ranking number 7 out of the top 20 employers across the life sciences.
“We are honored that the scientific community has recognized Merck Serono as a leading [...]